热门资讯> 正文
Labcorp考虑提高天花检测能力：报告
2024-08-27 04:20
- Labcorp (NYSE:LH) is reportedly considering ramping up its testing capacity for mpox amid a rising number of cases of the contagious disease.
- Labcorp (LH) processes around 500 tests a month for mpox, also known as monkeypox, but has the ability to scale up to approximately 25K a month. The company is working with US healthcare officials to determine if it needs to increase capacity, according to Reuters.
- The World Health Organization recently declared mpox a public health emergency amid the emergence of a more contagious variant of the virus, which is related to smallpox.
- Other providers of mpox testing services or products include Quest Diagnostics (DGX), Roche (OTCQX:RHHBY) and Abbott (ABT). Co-Diagnostics (CODX) and Applied DNA Sciences (APDN).
More on Laboratory Corporation of America
- Labcorp Holdings Inc (LH) Q2 2024 Earnings Call Transcript
- Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
- Laboratory Corporation of America beats top-line and bottom-line estimates; updates FY24 outlook
- Laboratory Corporation of America Q2 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Laboratory Corporation of America
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
